Captrust Financial Advisors Spectrum Pharmaceuticals Inc Transaction History

Captrust Financial Advisors

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.63 - $1.59 $233 - $588	-370 Reduced 30.45%	845 $1,000
Q4 2021 Feb 14, 2022	SELL	$1.27 - $2.42 $252 - $481	-199 Reduced 14.07%	1,215 $2,000
Q3 2021 Nov 16, 2021	SELL	$2.15 - $3.82 $6,931 - $12,315	-3,224 Reduced 69.51%	1,414 $3,000
Q2 2021 Aug 16, 2021	SELL	$2.89 - $4.45 $2,748 - $4,231	-951 Reduced 17.02%	4,638 $17,000
Q1 2021 May 17, 2021	BUY	$2.9 - $4.09 $14,801 - $20,875	5,104 Added 1052.37%	5,589 $18,000
Q4 2020 Feb 16, 2021	BUY	$3.38 - $5.14 $625 - $950	185 Added 61.67%	485 $2,000
Q3 2020 Nov 17, 2020	BUY	$2.99 - $4.9 $299 - $490	100 Added 50.0%	300 $1,000
Q2 2020 Aug 14, 2020	BUY	$2.11 - $3.38 $422 - $676	200 New	200 $1,000
Q4 2019 Feb 14, 2020	SELL	$3.5 - $10.35 $700 - $2,070	-200 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$7.36 - $11.26 $1,472 - $2,252	200 New	200 $2,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.